A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-linearity of BioChaperone® Combo 75/25 and the Safety at Three Different Doses in Subjects With Type 2 Diabetes
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Insulin glargine/insulin lispro (Primary) ; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Adocia
- 12 Jun 2017 According to an Adocia media release, data from this trial are expected in Q4 2017.
- 12 Jun 2017 According to an Adocia media release, this study is designed to answer an important regulatory requirement.
- 12 Jun 2017 New trial record